Hide Board Information

Show Board Information

PharmaCyte Biotech Inc. PMCB

Board Mod: Add me as mod

Asst Mods:

Last Post: 11/15/2023 8:10:49 AM

Board Marks: 56

Posts Today: 0

Board Views Today: 165

PharmaCyte Biotech Inc. (NASDAQ: PMCB) Stock Message Board

1. PMCB Company Profile

    

2. PMCB Time & Sales

    

3. PMCB Recent News

    

4. PMCB Filings

    

5. PMCB Financials

    

6. PMCB Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

10	Investors Confidently Back Nuvilex's Acquisition	stocklegend	12/09/2013 9:18:31 AM
9	$NVLX Nuvilex's Medical Marijuana Subsidiary	stocklegend	12/09/2013 8:49:49 AM
8	NVLX $.1325 Nuvilex's pancreatic cancer treatment	Roger Wilco	09/24/2013 3:36:08 PM
7	Nuvilex has recently acquired worldwide exclusive	Roger Wilco	09/24/2013 2:03:00 PM
6	Nuvilex is trying to cure serious, debilitating	Roger Wilco	09/24/2013 10:31:31 AM
5	NVLXNuvilex, Inc. (OTCQB:	cherrob	08/07/2013 9:23:16 AM
4	NVLX Nuvilex Inc. Research DD Guide	Rosner	04/23/2013 12:11:33 PM
3	a retrace below 3 triggers my buys	PowerPuncher	03/07/2013 1:21:24 PM
2	marketing could be the diff	PowerPuncher	03/05/2013 10:35:39 AM
1	I would like to know why on level 2 there are 4	magnoliarose	01/25/2013 10:29:47 AM

Newer

Recent Articles

• Understanding Potential Legal Claims Against Soleno Therapeutics
• GE Aerospace and UAW Achieve Tentative Labor Agreement
• Desay SV Unveils Innovative Concepts at IAA Mobility Event
• Investigation Launched into Fly-E Group, Inc. Securities Issues
• US Farmers Strengthen Trade Ties with China Amid Tensions
• Exciting Housing Initiative Announcement by Federal Government
• Investigation into Coty Inc. Reveals Potential Issues Ahead
• Desay SV Showcases Innovative Concepts at Major Mobility Event
• SpinLaunch's Innovative Technology Set to Transform Satellite Deployment
• Investigation Into Claims Against James Hardie Industries plc
• Controversial Claims Surround Sam Altman and OpenAI
• Valneva SE Faces Investigation Over Vaccine-Related Claims
• Mark Cuban's Passion for Disaster Movies and Their Chaos
• Investors Take Action: Axogen, Inc. Stock Investigation News
• Investigation into EHang Holdings: What Investors Should Know
• KinderCare Learning Companies Faces Class Action Lawsuit for IPO
• Purity ReSource's Innovative Water Tech for the Semiconductor Industry
• Dow Inc. Investors Alert: Class Action Lawsuit Update
• Exploring Investment Concerns Surrounding Skillz Inc. (NYSE: SKLZ)
• Investors Urged to Act: Novo Nordisk Lawsuit Information
• Investigating Cybin Inc.: Is There a Case for Investors?
• Understanding the Risks of Restaurant Startups in Today's Market
• Investigation into Agios Pharmaceuticals' Business Practices
• Concerns Arise Over John Bolton’s Email Breach and Security
• Explore the Rich Heritage at The Nuss Collection's Open House
• Quantum Corporation Faces Class Action Lawsuit Over Claims
• Investors Urged to Act: Tronox Holdings Faces Class Action Inquiry
• Investors Target Unicycive Therapeutics Amid Legal Actions
• Legal Insights: Investigating Nutex Health Investors' Options
• Unlock Greater Trading Potential with BexBack's Bonus Offer
• Investigation Launched into Semler Scientific by Law Firm
• Celebrate the Season with New Holiday Cheer Stamps Unveiled
• Tronox Holdings Faces Class Action Amid Financial Challenges
• Expert Issues Warning on Potential Stock Market Bubble
• Semler Scientific Faces Class Action Lawsuit Amid Stock Drops
• Investigation on Behalf of SelectQuote Investors: What You Should Know
• Important Legal Updates for Investors of Alto Neuroscience
• How J-P Conte Leverages Private Equity Principles for Community Resilience
• Upcoming Investors' Deadline: Explore Your Rights with PubMatic
• Investors Urged to Join Class Action Against LifeMD, Inc.
• Investors Urged to Act: Capitalize on Opportunities with Capricor
• Vitalik Buterin Highlights Security Risks of AI Technology
• Urgent Alert: Investors Advised to Act on Charter Communications
• Class Action Filed Against Snap, Inc. for Investor Securities Fraud
• Navigating Legal Proceedings: Insights for RxSight Investors
• LifeMD Investors Urged to Act Before Critical Deadline
• Investors Urged to Act: Lockheed Martin Securities Class Action
• Upcoming Class Action Lawsuit Against C3.ai, Inc. Explained
• Radioligand Therapy Market Growth Forecast to $10.9 Billion
• Unraveling Trump's $2 Trillion Strategy for Tech Dominance